Growth/Buyout Portfolio - Serb

SERB Specialty Pharmaceuticals

Key Figures

  • 1951
    Creation Date
  • 390
    Number of Employees
  • 2021
    Investment Date
  • Mérieux Participations 3
    Fund Name

Company Presentation

SERB Specialty Pharmaceuticals is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases. Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.

SERB is a global pharmaceutical group with a direct presence in Europe, in the Middle East and Australia, and over 80 countries including the US and Japan through a broad network of experienced distributors.


Avenue Louise 480 - 1050 Brussels - BELGIUM


Key Contacts